Genei Laboratories, a Bengaluru-based biotech company, has got the licence from IIT-Delhi to manufacture and commercialise the latter’s low-cost, real-time PCR diagnostic assay kit for Covid-19.
The National Biomedical Resource Indigenization Consortium (NBRIC), which facilitated the licensing, said IIT-Delhi is the first academic institute in India to get ICMR (Indian Council of Medical Research) approval for the indigenously developed kit.
As per the agreement, Genei Labs holds a non-exclusive licence from IIT-Delhi to scale up production and go to market with the kit. While standard RT-PCR kits in the market are probe-based, this design does away with probes completely. Instead, it detects Covid-19-specific RNA sequence in samples. As a result, the cost of testing is reduced to a fraction, making the kit affordable.
Genei will manufacture the kits in an exclusive Covid-19 testing kit manufacturing facility at the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam. The kit is expected to be rolled out in early June.
“We are thankful to IIT Delhi-and AMTZ for considering Genei Labs for further development and large-scale manufacture of this unique detection assay for Covid-19. Using Genei Labs’ expertise in reagent manufacturing and kit-making, we will ensure an accurate, affordable, Make-in-India RT-PCR kit for the diagnosis of Covid-19,” said S Chandrashekaran, Managing Director, Genei Laboratories.
Thank you for being a loyal user of Portfolio.
Portfolio will be a paid section hereon.
Please Subscribe to get access to one of our early bird packs.
Or click on Free Trial to get 14 days free trial.
What You'll Get
-
Web + Mobile
Access exclusive content of the Hindu Businessline across desktops, tablet and mobile device.
-
Exclusive Portfolio and Investment Advice, Banking, Lifestyle and Specials
Get diverse set of perspectives from our trusted experts on Portfolio, Banking, Economy, Environment and others.
-
Ad free experience
Experience cleaner site with zero ads and faster load times.
-
Personalised dashboard
Customize your preference and get a personalized recommendation of stories based on your interest.
Published on
June 03, 2020
A letter from the Editor
Dear Readers,
The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.
Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.
In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.
We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.
But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.
I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.
A little help from you can make a huge difference to the cause of quality journalism!
Support Quality Journalism